GlassScriptPhysician profile
Takiyah A Mitchell
NPI 1215490321
$910.11
in general payments reported to CMS, 2019-2025
16 companies · $649 in 2025
The $649 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $82.08 · 2024: $179 · 2025: $649.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $751 · Travel and Lodging: $145 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $751.42 |
| Travel and Lodging | $145.34 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $348.52 | 2025 | |
| Astellas Pharma US INC | $120.59 | 2024-2025 | Veozah |
| Millicent US INC | $66.20 | 2023-2025 | Intrarosa, Femring |
| Sumitomo Pharma America, INC. | $60.00 | 2024-2025 | Myfembree, Gemtesa |
| Mimedx Group, INC. | $43.90 | 2025 | |
| Sage Therapeutics, LLC | $36.91 | 2025 | Zurzuvae |
| Supernus Pharmaceuticals, INC. | $36.91 | 2025 | Qelbree |
| Exeltis, USA INC. | $34.13 | 2025 | Slynd |
| Evofem Biosciences, INC. | $32.15 | 2023-2024 | Phexxi |
| Ethicon US, LLC | $26.95 | 2024 | Stratafix, Ethicon |
| Exact Sciences Corporation | $25.22 | 2025 | The Cologuard Plus Collection Kit |
| Mayne Pharma Commercial LLC | $17.00 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.00 | 2024 | Xifaxan, Trulance |
| Merck Sharp & Dohme LLC | $16.11 | 2023 | Gardasil 9 |
| Agile Therapeutics, INC. | $14.88 | 2024 | Twirla |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $13.64 | 2025 | Paragard T 380a |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Takiyah Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.